Who owns CYTOKINETICS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CYTK from SEC Form 13F filings across 469 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 469 institutions disclosed 168.2M shares of CYTOKINETICS INC worth $10.64B — about 120990.6% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
469
13F holders
$10.64B
value, 2026 filers
120990.6%
of shares outstanding (168.2M sh)
65
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CYTK's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 21.0M | $1.39B | 0.0% | 15132.6% | +4.7% |
| 2 | T. Rowe Price Investment Management, Inc. | 18.9M | $1.25B | 0.9% | 13601.9% | +1.0% |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 10.6M | $698.0M | 0.1% | 7616.5% | +52.8% |
| 4 | Polar Capital Holdings Plc | 9.6M | $227.7M | 0.6% | 6929.6% | +327.5% |
| 5 | STATE STREET CORP | 7.1M | $470.8M | 0.0% | 5137.4% | +10.0% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.8M | $448.2M | 0.0% | 4890.2% | +1.3% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 6.3M | $413.0M | 0.0% | 4506.8% | +2.4% |
| 8 | Avoro Capital Advisors LLC | 4.9M | $323.0M | 3.3% | 3524% | -2.0% |
| 9 | BANK OF AMERICA CORP /DE/ | 4.7M | $312.1M | 0.0% | 3405.6% | +2.1% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 3.8M | $248.4M | 0.0% | 2709.8% | +1.5% |
| 11 | Invesco Ltd. | 3.0M | $198.8M | 0.0% | 2169.5% | +144.2% |
| 12 | RTW INVESTMENTS, LP | 2.9M | $188.6M | 1.9% | 2058.3% | 0.0% |
| 13 | Capital Research Global Investors | 2.4M | $161.2M | 0.0% | 1759.4% | +45.0% |
| 14 | FMR LLC | 2.2M | $146.7M | 0.0% | 1600.8% | -55.8% |
| 15 | GOLDMAN SACHS GROUP INC | 1.8M | $121.9M | 0.0% | 1330.1% | +5.0% |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.7M | $113.7M | 0.0% | 1240.8% | +10.2% |
| 17 | NORTHERN TRUST CORP | 1.7M | $109.1M | 0.0% | 1190.4% | +0.5% |
| 18 | JPMORGAN CHASE & CO | 1.6M | $107.5M | 0.0% | 1172.8% | +2.6% |
| 19 | Integral Health Asset Management, LLC | 1.6M | $72.5M | 4.4% | 1150.7% | 0.0% |
| 20 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.6M | $104.2M | 0.0% | 1136.5% | -19.3% |
| 21 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.6M | $103.9M | 0.3% | 1133.5% | -1.7% |
| 22 | TWO SIGMA INVESTMENTS, LP | 1.6M | $103.2M | 0.1% | 1125.9% | +393.2% |
| 23 | Pictet Asset Management Holding SA | 1.4M | $90.6M | 0.1% | 988.5% | +18.4% |
| 24 | MORGAN STANLEY | 1.4M | $89.8M | 0.0% | 979.9% | -9.8% |
| 25 | PRINCIPAL FINANCIAL GROUP INC | 1.2M | $80.8M | 0.0% | 881.4% | -6.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.